Statins and Elderly: From Clinical Trials to Daily Practice

Area of Science:

• Gerontology
• Cardiology
• Pharmacology

Background:

• Elderly populations are growing, presenting challenges in managing atherothrombotic disease.
• Cardiovascular risk management in older adults requires balancing benefits against complexity, frailty, and comorbidities.

Purpose of the Study:

• To address the "statin paradox" where high-risk elderly patients may be undertreated.
• To highlight the need for better guidance on statin use in the elderly, particularly for primary prevention.

Main Methods:

• Review of existing literature and clinical trial data concerning statin use in elderly patients.
• Analysis of barriers to statin therapy in older adults, including altered metabolism, polypharmacy, and drug interactions.

Main Results:

• Elderly patients are often excluded from major statin trials, limiting evidence for their advanced age.
• Potential risks and financial constraints contribute to undertreatment, creating a "statin paradox".

Conclusions:

• Despite challenges, the cardiovascular benefits of statins in the elderly cannot be ignored.
• Clinicians need better tools for individualized decisions regarding statin therapy in older adults.